
Topic
Boxed Warning
Boxed warning label changes, safety restrictions, payer reactions, and commercial implications for prescribing.

Policy· July 25, 2026 · 28 min read
By Ran Chen#Label Warnings#Boxed Warning#FDA Approval

Evidence· July 13, 2026 · 16 min read
ADHD Medications in FAERS: 194,052 Adverse-Event Reports by the Numbers

Pricing & Access· July 13, 2026 · 17 min read
Duchenne Muscular Dystrophy Access Landscape: Elevidys, Oligonucleotides, and Duvyzat
By Ran Chen#Rare Disease#Gene Therapy#HCPCS Coding

Evidence· July 9, 2026 · 16 min read
Benzodiazepines in FAERS: Adverse Events, Dependence, and Safety Signals

Policy· June 28, 2026 · 19 min read
How to Read an FDA REMS: ETASU, Shared vs. Single REMS, and the Patent Dance
By Ran Chen#REMS#Generics#FDA Approval

Policy· June 14, 2026 · 13 min read
How to read an FDA FAERS report: what spontaneous reporting can and cannot prove

Policy· June 14, 2026 · 12 min read